229 related articles for article (PubMed ID: 15004704)
1. Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma.
Kutter J; Ozsahin M; Monnier P; Stupp R
Eur Arch Otorhinolaryngol; 2005 Jan; 262(1):1-7. PubMed ID: 15004704
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
[TBL] [Abstract][Full Text] [Related]
3. Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study.
Bensadoun RJ; Etienne MC; Dassonville O; Chauvel P; Pivot X; Marcy PY; Prevost B; Coche-Dequeant B; Bourdin S; Vallicioni J; Poissonnet G; Courdi A; Teissier E; Lagrange JL; Thyss A; Santini J; Demard F; Schneider M; Milano G
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):237-45. PubMed ID: 9788400
[TBL] [Abstract][Full Text] [Related]
4. Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.
Semrau S; Waldfahrer F; Lell M; Linke R; Klautke G; Kuwert T; Uder M; Iro H; Fietkau R
Strahlenther Onkol; 2011 Jan; 187(1):15-22. PubMed ID: 21234526
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: a feasibility study.
Vikram B; Malamud S; Gold J; Nussbaum M; Kimmelman C; Lucente F; Pavlou W; Pisch J; Chadha M; Beattie E
Head Neck; 1991; 13(5):415-9. PubMed ID: 1938358
[TBL] [Abstract][Full Text] [Related]
6. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy rapidly alternating with twice-a-day accelerated radiation therapy in carcinomas involving the hypopharynx or esophagus: an update.
Yu L; Vikram B; Malamud S; Yudelman I; Nussbaum M; Beattie E
Cancer Invest; 1995; 13(6):567-72. PubMed ID: 7583705
[TBL] [Abstract][Full Text] [Related]
8. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
[TBL] [Abstract][Full Text] [Related]
9. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
[TBL] [Abstract][Full Text] [Related]
10. [The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].
Sola B; Airoldi M; Orecchia R; Rovea P; Fracchia F; Boidi Trotti A; Tessa M; Foco A; Oliaro A; Casadio C; Dei Poli M
Radiol Med; 1996 Apr; 91(4):456-9. PubMed ID: 8643859
[TBL] [Abstract][Full Text] [Related]
11. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
12. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
Hassan E; Galal K; Esmat E
Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
[TBL] [Abstract][Full Text] [Related]
14. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
de Crevoisier R; Mazeron JJ
Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
[No Abstract] [Full Text] [Related]
15. [Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept].
Dietz A; Rudat V; Nollert J; Flentje M; Maiei H; Wannenmacher M; Weidauer H
Laryngorhinootologie; 1996 Dec; 75(12):745-53. PubMed ID: 9081280
[TBL] [Abstract][Full Text] [Related]
16. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
17. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
Ghi MG; Paccagnella A; D'Amanzo P; Mione CA; Fasan S; Paro S; Mastromauro C; Carnuccio R; Turcato G; Gatti C; Pallini A; Nascimben O; Biason R; Oniga F; Medici M; Rossi F; Fila G
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):481-7. PubMed ID: 15145166
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.
Calais G; Dorval E; Louisot P; Bourlier P; Klein V; Chapet S; Reynaud-Bougnoux A; Huten N; De Calan L; Aget H; Le Floch O
Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):769-75. PubMed ID: 9240645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
